Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 3/20 | 0.32 |
| ▸ | NOS2 | P35228 | 3/20 | 0.32 |
| ▸ | NOS3 | P29474 | 2/20 | 0.32 |
| ▸ | NAAA | Q02083 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11135927 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2FUT7 | |
| SCHEMBL11463750 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2FUT7 | |
| SCHEMBL9787943 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2FUT7 | |
| SCHEMBL10616810 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2FUT7 | |
| SCHEMBL11653482 | 1.00 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2FUT7 | |
| SCHEMBL11467223 | 0.92 | EPHX2 (0.38) | ALDH1A1 | |
| SCHEMBL11467225 | 0.92 | EPHX2 (0.38) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2422211 | 0.90 | — | — | |
| SCHEMBL1741640 | 0.81 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2NAAA | |
| SCHEMBL10617495 | 0.81 | ALDH1A1 (0.33) | ALDH1A1PKMHPGDKCNH2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4876249-A | TOPICAL; TRANSDERMAL, SYSTEMIC; FLUOCINOLINE ACETONIDE AND IMIDAZOLINE OR OXAZOLINE PENETRATION ENHANCER MIXTURE; THERAPEUTIC DRUGS | THERAPEUTIC PATCH RESEARCH N.V. | 1989-10-24 | — | — | US | claimed |
| EP-0296199-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA, Vithal J. (US) | 1988-12-28 | — | — | EP | claimed |
| WO-1988004938-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA VITHAL J (US) | 1988-07-14 | — | — | WO | claimed |
| EP-0622357-B1 | Process for the production of cyclic amidine | LION AKZO COMPANY LIMITED (JP) | 1996-11-06 | — | — | EP | disclosed |
| US-5380899-A | Process for the production of cyclic amidine | LION AKZO CO., LTD. (JP) | 1995-01-10 | — | — | US | disclosed |
| EP-0622357-A1 | Process for the production of cyclic amidine | LION AKZO COMPANY LIMITED (JP) | 1994-11-02 | — | — | EP | disclosed |
| US-5030629-A | Transdermal Administration Of Cardiovascular Agents | THERAPEUTIC PATCH RESEARCH N.V. | 1991-07-09 | — | — | US | disclosed |
| US-4876249-A | TOPICAL; TRANSDERMAL, SYSTEMIC; FLUOCINOLINE ACETONIDE AND IMIDAZOLINE OR OXAZOLINE PENETRATION ENHANCER MIXTURE; THERAPEUTIC DRUGS | THERAPEUTIC PATCH RESEARCH N.V. | 1989-10-24 | — | — | US | disclosed |
| EP-0296199-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA, Vithal J. (US) | 1988-12-28 | — | — | EP | disclosed |
| WO-1988004938-A1 | HETEROCYCLIC COMPOUNDS FOR TRANSDERMAL USE | RAJADHYAKSHA VITHAL J (US) | 1988-07-14 | — | — | WO | disclosed |
| US-4185098-A | (COCO-AMINO)ALKYL PHOSPHONATE INNER SALT AND N,N-DIMETHYL-N-(3-LAUROYLAMIDOPROPYL)AMINE | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-01-22 | — | — | US | disclosed |